Search

Ziaul Karim

Examiner (ID: 14835, Phone: (571)270-3279 , Office: P/2127 )

Most Active Art Unit
2119
Art Unit(s)
2127, 2119
Total Applications
971
Issued Applications
802
Pending Applications
63
Abandoned Applications
133

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18955149 [patent_doc_number] => 20240043476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => ANTI-TUMOR PEPTIDE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/761255 [patent_app_country] => US [patent_app_date] => 2021-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6561 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17761255 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/761255
ANTI-TUMOR PEPTIDE AND USE THEREOF Aug 17, 2021 Abandoned
Array ( [id] => 17428366 [patent_doc_number] => 20220056074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES [patent_app_type] => utility [patent_app_number] => 17/401434 [patent_app_country] => US [patent_app_date] => 2021-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -58 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17401434 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/401434
PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES Aug 12, 2021 Pending
Array ( [id] => 17760020 [patent_doc_number] => 20220233632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => MODULATORS OF COMPLEMENT ACTIVITY [patent_app_type] => utility [patent_app_number] => 17/400267 [patent_app_country] => US [patent_app_date] => 2021-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17400267 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/400267
Modulators of complement activity Aug 11, 2021 Issued
Array ( [id] => 19097757 [patent_doc_number] => 20240116985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => STAPLED PEPTIDES AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 18/017024 [patent_app_country] => US [patent_app_date] => 2021-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 149578 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18017024 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/017024
STAPLED PEPTIDES AND METHODS THEREOF Jul 21, 2021 Pending
Array ( [id] => 17214492 [patent_doc_number] => 20210347829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => ARC-BASED CAPSIDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/382092 [patent_app_country] => US [patent_app_date] => 2021-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32028 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17382092 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/382092
Endogenous Gag-based capsids and uses thereof Jul 20, 2021 Issued
Array ( [id] => 18629526 [patent_doc_number] => 20230288408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => NOVEL PEPTIDE TAG [patent_app_type] => utility [patent_app_number] => 18/015906 [patent_app_country] => US [patent_app_date] => 2021-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015906 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015906
NOVEL PEPTIDE TAG Jul 14, 2021 Pending
Array ( [id] => 19594224 [patent_doc_number] => 12152054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-26 [patent_title] => Methods of purifying polypeptides [patent_app_type] => utility [patent_app_number] => 17/369765 [patent_app_country] => US [patent_app_date] => 2021-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 74 [patent_no_of_words] => 31190 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17369765 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/369765
Methods of purifying polypeptides Jul 6, 2021 Issued
Array ( [id] => 18510048 [patent_doc_number] => 20230226146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-20 [patent_title] => ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) [patent_app_type] => utility [patent_app_number] => 18/011261 [patent_app_country] => US [patent_app_date] => 2021-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -207 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011261 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011261
ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) Jun 21, 2021 Pending
Array ( [id] => 18177909 [patent_doc_number] => 20230038638 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-09 [patent_title] => COMPLEMENT FACTOR I-RELATED COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/347442 [patent_app_country] => US [patent_app_date] => 2021-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55653 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17347442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/347442
Complement factor I-related compositions and methods Jun 13, 2021 Issued
Array ( [id] => 18692558 [patent_doc_number] => 20230322856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION [patent_app_type] => utility [patent_app_number] => 17/997808 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7224 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997808
COMPOSITION COMPRISING REGENTIDE-012 OR REGENTIDE-013 FOR IMPROVING SKIN CONDITION Jun 7, 2021 Pending
Array ( [id] => 18391372 [patent_doc_number] => 20230159590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION [patent_app_type] => utility [patent_app_number] => 17/997801 [patent_app_country] => US [patent_app_date] => 2021-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6851 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997801 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/997801
REGENTIDE-041 AND COMPOSITION COMPRISING REGENTIDE-041 FOR IMPROVING SKIN CONDITION Jun 7, 2021 Pending
Array ( [id] => 18496156 [patent_doc_number] => 20230218707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => NOVEL PEPTIDE INHIBITORS OF BETA-LACTAMASE AGAINST ANTIBIOTIC RESISTANCE [patent_app_type] => utility [patent_app_number] => 17/999974 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999974 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999974
NOVEL PEPTIDE INHIBITORS OF BETA-LACTAMASE AGAINST ANTIBIOTIC RESISTANCE Jun 3, 2021 Pending
Array ( [id] => 18530231 [patent_doc_number] => 20230235301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-27 [patent_title] => Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis [patent_app_type] => utility [patent_app_number] => 18/000644 [patent_app_country] => US [patent_app_date] => 2021-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18000644 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/000644
Compounds and Methods for Treating, Ameliorating, or Preventing Herpes Ocular Keratitis Jun 2, 2021 Pending
Array ( [id] => 17110193 [patent_doc_number] => 20210290790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => METHOD FOR PRODUCING PROTEIN COMPOSITION, AND PROTEIN COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/336672 [patent_app_country] => US [patent_app_date] => 2021-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11859 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17336672 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/336672
Method for producing protein composition, and protein composition Jun 1, 2021 Issued
Array ( [id] => 17776566 [patent_doc_number] => 20220242915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-04 [patent_title] => SODIUM CHANNEL PROTEIN NAV1.4-TARGETING POLYPEPTIDE AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/329194 [patent_app_country] => US [patent_app_date] => 2021-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3075 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17329194 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/329194
Sodium channel protein Nav1.4-targeting polypeptide and use thereof May 24, 2021 Issued
Array ( [id] => 19550967 [patent_doc_number] => 12134664 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-05 [patent_title] => Muramyl peptide derivatives [patent_app_type] => utility [patent_app_number] => 17/328078 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 13187 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328078
Muramyl peptide derivatives May 23, 2021 Issued
Array ( [id] => 17082051 [patent_doc_number] => 20210277057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/328045 [patent_app_country] => US [patent_app_date] => 2021-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1772 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17328045 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/328045
ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS May 23, 2021 Abandoned
Array ( [id] => 17185231 [patent_doc_number] => 20210332116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => SINGLE DOMAIN BINDING MOLECULE [patent_app_type] => utility [patent_app_number] => 17/322139 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322139 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322139
Single domain binding molecule May 16, 2021 Issued
Array ( [id] => 17228912 [patent_doc_number] => 20210355468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA [patent_app_type] => utility [patent_app_number] => 17/320386 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26686 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17320386 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/320386
COMPOSITIONS AND METHODS FOR TREATING LEWY BODY DEMENTIA May 13, 2021 Abandoned
Array ( [id] => 17299479 [patent_doc_number] => 20210395318 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => MULTISPECIFIC PROTEINS [patent_app_type] => utility [patent_app_number] => 17/302898 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44923 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17302898 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/302898
Multispecific proteins May 13, 2021 Issued
Menu